Daewon to launch new anti-inflammatory drug in October
Peluvi is Korea’s 12th homegrown anti-inflammatory agent, which was developed as a result of intensive R&D efforts...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
